vs
Side-by-side financial comparison of Dexcom (DXCM) and SOMNIGROUP INTERNATIONAL INC. (SGI). Click either name above to swap in a different company.
SOMNIGROUP INTERNATIONAL INC. is the larger business by last-quarter revenue ($1.9B vs $1.3B, roughly 1.5× Dexcom). Dexcom runs the higher net margin — 21.2% vs 7.5%, a 13.7% gap on every dollar of revenue. On growth, SOMNIGROUP INTERNATIONAL INC. posted the faster year-over-year revenue change (54.7% vs 21.6%). Over the past eight quarters, SOMNIGROUP INTERNATIONAL INC.'s revenue compounded faster (25.3% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Somnigroup International Inc. is an American manufacturer of mattresses and bedding products.
DXCM vs SGI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.9B |
| Net Profit | $267.3M | $140.8M |
| Gross Margin | 62.9% | 44.0% |
| Operating Margin | 25.6% | 13.2% |
| Net Margin | 21.2% | 7.5% |
| Revenue YoY | 21.6% | 54.7% |
| Net Profit YoY | 153.6% | 95.8% |
| EPS (diluted) | $0.67 | $0.71 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.9B | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.2B | $1.9B | ||
| Q1 25 | $1.0B | $1.6B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $994.2M | $1.3B | ||
| Q2 24 | $1.0B | $1.2B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $140.8M | ||
| Q3 25 | $283.8M | $177.4M | ||
| Q2 25 | $179.8M | $99.0M | ||
| Q1 25 | $105.4M | $-33.1M | ||
| Q4 24 | $151.7M | $71.9M | ||
| Q3 24 | $134.6M | $130.0M | ||
| Q2 24 | $143.5M | $106.1M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 44.0% | ||
| Q3 25 | 60.5% | 44.9% | ||
| Q2 25 | 59.5% | 44.0% | ||
| Q1 25 | 56.9% | 36.2% | ||
| Q4 24 | 58.9% | 43.3% | ||
| Q3 24 | 59.7% | 45.4% | ||
| Q2 24 | 62.4% | 44.9% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 13.2% | ||
| Q3 25 | 20.1% | 14.8% | ||
| Q2 25 | 18.4% | 9.6% | ||
| Q1 25 | 12.9% | 0.8% | ||
| Q4 24 | 17.0% | 10.6% | ||
| Q3 24 | 15.3% | 15.5% | ||
| Q2 24 | 15.7% | 14.0% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 7.5% | ||
| Q3 25 | 23.5% | 8.4% | ||
| Q2 25 | 15.5% | 5.3% | ||
| Q1 25 | 10.2% | -2.1% | ||
| Q4 24 | 13.6% | 6.0% | ||
| Q3 24 | 13.5% | 10.0% | ||
| Q2 24 | 14.3% | 8.6% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.71 | ||
| Q3 25 | $0.70 | $0.83 | ||
| Q2 25 | $0.45 | $0.47 | ||
| Q1 25 | $0.27 | $-0.17 | ||
| Q4 24 | $0.37 | $0.40 | ||
| Q3 24 | $0.34 | $0.73 | ||
| Q2 24 | $0.35 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | $4.6B |
| Stockholders' EquityBook value | $2.7B | $3.1B |
| Total Assets | $6.3B | $11.6B |
| Debt / EquityLower = less leverage | — | 1.47× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $4.6B | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.8B | ||
| Q1 25 | — | $4.9B | ||
| Q4 24 | — | $3.7B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.4B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $3.1B | ||
| Q3 25 | $2.7B | $3.0B | ||
| Q2 25 | $2.6B | $2.8B | ||
| Q1 25 | $2.3B | $2.7B | ||
| Q4 24 | $2.1B | $559.0M | ||
| Q3 24 | $2.0B | $564.5M | ||
| Q2 24 | $2.4B | $411.8M |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $11.6B | ||
| Q3 25 | $7.5B | $11.4B | ||
| Q2 25 | $7.3B | $11.4B | ||
| Q1 25 | $6.8B | $11.3B | ||
| Q4 24 | $6.5B | $6.0B | ||
| Q3 24 | $6.4B | $4.6B | ||
| Q2 24 | $6.8B | $4.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.47× | ||
| Q3 25 | — | 1.51× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | — | 6.69× | ||
| Q3 24 | — | 3.95× | ||
| Q2 24 | — | 5.92× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $99.4M |
| Free Cash FlowOCF − Capex | — | $41.1M |
| FCF MarginFCF / Revenue | — | 2.2% |
| Capex IntensityCapex / Revenue | — | 3.1% |
| Cash ConversionOCF / Net Profit | — | 0.71× |
| TTM Free Cash FlowTrailing 4 quarters | — | $633.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $99.4M | ||
| Q3 25 | $659.9M | $408.2M | ||
| Q2 25 | $303.0M | $186.1M | ||
| Q1 25 | $183.8M | $106.4M | ||
| Q4 24 | $301.4M | $129.1M | ||
| Q3 24 | $199.5M | $256.6M | ||
| Q2 24 | $279.4M | $150.6M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $41.1M | ||
| Q3 25 | $579.4M | $360.3M | ||
| Q2 25 | $208.9M | $149.4M | ||
| Q1 25 | $96.8M | $82.4M | ||
| Q4 24 | $176.8M | $108.2M | ||
| Q3 24 | $88.3M | $240.2M | ||
| Q2 24 | $213.3M | $122.1M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 2.2% | ||
| Q3 25 | 47.9% | 17.0% | ||
| Q2 25 | 18.1% | 7.9% | ||
| Q1 25 | 9.3% | 5.1% | ||
| Q4 24 | 15.9% | 9.0% | ||
| Q3 24 | 8.9% | 18.5% | ||
| Q2 24 | 21.2% | 9.9% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 3.1% | ||
| Q3 25 | 6.7% | 2.3% | ||
| Q2 25 | 8.1% | 2.0% | ||
| Q1 25 | 8.4% | 1.5% | ||
| Q4 24 | 11.2% | 1.7% | ||
| Q3 24 | 11.2% | 1.3% | ||
| Q2 24 | 6.6% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 0.71× | ||
| Q3 25 | 2.33× | 2.30× | ||
| Q2 25 | 1.69× | 1.88× | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.99× | 1.80× | ||
| Q3 24 | 1.48× | 1.97× | ||
| Q2 24 | 1.95× | 1.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
SGI
| Mattress Firm Segment | $892.1M | 48% |
| Tempur Sealy North America Segment | $620.5M | 33% |
| Tempur Sealy International Segment | $355.8M | 19% |
